Orthopedic, Prosthetic & Surgical Appliances & Supplies · OR AKIVA, 46, Israel
$2.54
-25.51% (-$0.87)2026-07-14
Smart-Money SignalNeutral · 53/100— Insider open-market flow is flat over 90 days
Price Performance
Historical data including institutional events
Company Profile
E
Ehud Geller
CEO & Executive Director
Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States.
It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee.
The company was incorporated in 2004 and is based in Herzliya, Israel.
